Showing results (1101-1110 of 1,243) with videos related to
Sort By:
Pageof 125
American Heart Journal|March 21, 2016
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trialRury R Holman, Mary Angelyn Bethel, Jyothis George, et al.Journal of Cardiac Failure|April 24, 2022
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF TrialBradi B Granger, Lisa A Kaltenbach, Gregg C Fonarow, et al.JACC. Heart Failure|July 10, 2020
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE TrialDouglas L Mann, Stephen J Greene, Michael M Givertz, et al.Journal of the American Heart Association|September 8, 2022
Heart Failure Strategically Focused Research Network: Summary of Results and Future DirectionsG Michael Felker, Peter Buttrick, Anthony Rosenzweig, et al.The Lancet. Diabetes & Endocrinology|November 13, 2022
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trialSilvio E Inzucchi, Brian L Claggett, Muthiah Vaduganathan, et al.JACC. Heart Failure|May 25, 2023
Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection FractionJohn W Ostrominski, Jorge Thierer, Brian L Claggett, et al.Circulation|August 26, 2023
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER TrialSafia Chatur, Muthiah Vaduganathan, Brian L Claggett, et al.European Journal of Heart Failure|July 6, 2012
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF studyG Michael Felker, Vic Hasselblad, W H Wilson Tang, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 28, 2020
Machine-Learning-Based In-Hospital Mortality Prediction for Transcatheter Mitral Valve Repair in the United StatesDagmar F Hernandez-Suarez, Sagar Ranka, Yeunjung Kim, et al.European Journal of Heart Failure|May 22, 2023
Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant-level pooled analysis from the DAPA-HF and DELIVER trialsAnkeet S Bhatt, Mikhail N Kosiborod, Muthiah Vaduganathan, et al.Pageof 125